Evidence map›Paper›PMID 35384175›Full record

ArticleJournal of applied microbiology2022

Priming with biocides: A pathway to antibiotic resistance?

Pat Adkin, Andrew Hitchcock, Laura J Smith, Susannah E Walsh

Open access · hybridAbstract read
In one paragraph

Article in Journal of applied microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Veterinary and animal science · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Tolerance ofBiofilm · 2024
    Article
  7. Article
  8. Review
  9. Biocide Susceptibility and Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Priming with biocides: A pathway to antibiotic resistance?Journal of applied microbiology · 2022
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Pat AdkinLeicester School of Pharmacy, Hawthorn Building, De Montfort University, Leicester, UK.
Andrew HitchcockSchool of Biosciences, University of Sheffield, Sheffield, UK.ORCID https://orcid.org/0000-0001-6572-434X
Laura J SmithLeicester School of Pharmacy, Hawthorn Building, De Montfort University, Leicester, UK.
Susannah E WalshLeicester School of Pharmacy, Hawthorn Building, De Montfort University, Leicester, UK.ORCID https://orcid.org/0000-0002-4324-0229
De Montfort University · GBRobert Gordon University · GBUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo investigate the priming effects of sub-inhibitory concentrations of biocides on antibiotic resistance in bacteria. METHODS AND

resultsEscherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus were exposed to sub-inhibitory concentrations of biocides via a gradient plate method. Minimum inhibitory concentration (MIC) and antibiotic susceptibility were determined, and efflux pump inhibitors (thioridazine and chlorpromazine) were used to investigate antibiotic resistance mechanism(s). Escherichia coli displayed a twofold increase in MIC (32-64 mg l

conclusionsThese findings demonstrate that sub-inhibitory concentrations of biocides can prime bacteria to become resistant to antibiotics even in the absence of stable biocide tolerance and suggests activation of efflux mechanisms may be a contributory factor. SIGNIFICANCE AND IMPACT OF THE STUDY: This study demonstrates the effects of low-level exposure of biocides (priming) on antibiotic resistance even in the absence of obvious increased biocidal tolerance.

Indexed as

DisinfectantsAnti-Bacterial AgentsCephalothinChlorpromazineDrug Resistance, BacterialEscherichia coliMicrobial Sensitivity TestsOxacillinPseudomonas aeruginosaStaphylococcus aureusThioridazineAnti-Bacterial AgentsCephalothinChlorpromazineDisinfectantsOxacillinThioridazine

Identifiers

PMID35384175
PMCPMC9543593
OpenAlexW4225547418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.